6 research outputs found
Rifaximin Exerts Beneficial Effects Independent of its Ability to Alter Microbiota Composition
Rifaximin has clinical benefits in minimal hepatic encephalopathy (MHE) but the mechanism of action is unclear. The antibiotic-dependent and -independent effects of rifaximin need to be elucidated in the setting of MHE-associated microbiota. To assess the action of rifaximin on intestinal barrier, inflammatory milieu and ammonia generation independent of microbiota using rifaximin
Gut microbiota drive the development of neuroinflammatory response in cirrhosis in mice: HEPATOLOGY, VOL. XX, NO. X KANG ET AL.
The mechanisms behind the development of hepatic encephalopathy (HE) are unclear although hyperammonemia and systemic inflammation through gut dysbiosis have been proposed